{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "ORPHAN DRUG|Designated/Withdrawn" in comments (approximate match)
Status:
Designated
Source:
FDA ORPHAN DRUG:625417
Source URL:
Class:
PROTEIN
Status:
Designated
Source:
FDA ORPHAN DRUG:66392
Source URL:
Class:
PROTEIN
Status:
Designated
Source:
EU-Orphan Drug:EU/3/03/138
Source URL:
Class:
PROTEIN
Status:
US Previously Marketed
Source:
Amevive
(2003)
Source URL:
First approved in 2003
Source:
Amevive
Source URL:
Class:
PROTEIN
Status:
US Previously Marketed
Source:
MYOSCINT by CENTOCOR INC
(1996)
Source URL:
First approved in 1996
Source:
MYOSCINT by CENTOCOR INC
Source URL:
Class:
PROTEIN
Status:
US Previously Marketed
First marketed in 1921
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
21 CFR 347
(2017)
Source URL:
First approved in 2017
Source:
21 CFR 347
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
Ontosein by Gruenenthal [W. Germany]
Source URL:
First approved in 2015
Source:
21 CFR 352
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
21 CFR 346
(2012)
Source URL:
First approved in 2011
Source:
21 CFR 355
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
Dermaheal Cosmeceutical Mask Pack Plus by YBK Investment, INC
Source URL:
First approved in 2008
Source:
21 CFR 333D
Source URL:
Class:
PROTEIN
